F2 and Increased total leukocyte count: Work by this group has demonstrated that humanized monoclonal PT-targeted antibodies constructed from efficacious murine antibody clones 1B7 and 11E6 [42] were able to mitigate B. pertussis-induced leukocytosis in baboons when administered prophylactically and at therapeutic time points [45].